Tower Research Capital LLC (TRC) - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 227 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$146,496
+279.3%
5,377
+209.7%
0.01%
+400.0%
Q2 2023$38,626
+386160.0%
1,736
+255.7%
0.00%
Q4 2022$10
-100.0%
488
-89.5%
0.00%
-100.0%
Q3 2022$119,000
+52.6%
4,641
+41.1%
0.00%0.0%
Q2 2022$78,000
-32.8%
3,288
-35.8%
0.00%
+100.0%
Q1 2022$116,000
+20.8%
5,119
+5.5%
0.00%
-50.0%
Q4 2021$96,000
+95.9%
4,850
+92.7%
0.00%
+100.0%
Q3 2021$49,000
-82.0%
2,517
-79.6%
0.00%
-85.7%
Q2 2021$272,000
+7.9%
12,363
+16.9%
0.01%
+75.0%
Q1 2021$252,000
+200.0%
10,576
+229.9%
0.00%
+33.3%
Q4 2020$84,000
-93.2%
3,206
-95.5%
0.00%
-78.6%
Q3 2020$1,233,000
+445.6%
70,803
+427.2%
0.01%
+55.6%
Q2 2020$226,000
+1089.5%
13,430
+878.9%
0.01%
+800.0%
Q3 2019$19,000
+137.5%
1,372
+102.1%
0.00%0.0%
Q2 2019$8,000
-68.0%
679
-56.9%
0.00%0.0%
Q2 2018$25,000
+177.8%
1,575
+195.5%
0.00%0.0%
Q1 2018$9,000
-95.5%
533
-94.9%
0.00%
-94.1%
Q3 2017$201,000
+20000.0%
10,397
+9526.9%
0.02%
Q1 2017$1,000
-97.8%
108
-98.3%
0.00%
-100.0%
Q4 2016$46,000
+155.6%
6,353
+78.5%
0.01%
+66.7%
Q4 2015$18,000
-64.7%
3,559
-57.6%
0.00%
-40.0%
Q2 2015$51,000
+168.4%
8,389
+144.8%
0.01%
+150.0%
Q1 2015$19,000
-5.0%
3,427
-54.0%
0.00%0.0%
Q3 2014$20,000
+66.7%
7,456
+77.5%
0.00%0.0%
Q2 2014$12,0004,201
+4101.0%
0.00%
Q3 2013$0
-100.0%
100
-95.0%
0.00%
Q2 2013$3,0002,0000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders